The FDA Ruled That ZYN Pouches Are Safer Than Cigarettes. That Doesn’t Mean They’re Safe
Key takeaways
- The decision does not mean nicotine pouches are safe or approved as smoking cessation products.
- The regulatory green light comes at a time wheN the nicotine-pouch boom has already reshaped the conversation about alternatives to smoking.
- It’s the first time regulators have formally endorsed an idea that many younger nicotine users had already embraced.
Why this matters: a development in AI with implications for how people work, create, and decide.
Photo-Illustration: WIRED MIDDLE EAST; GETTY IMAGESComment Loader Save Story Save this story Comment Loader Save Story Save this story On June 30, the US Food and Drug Administration authorized 20 ZYN nicotine pouch products to carry a specific “modified risk” claim. This means that in the US, ZYN can now assert that “using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.”
The decision does not mean nicotine pouches are safe or approved as smoking cessation products. It simply allows Swedish Match, which manufactures ZYN, to market certain products as a less harmful alternative for adults who completely switch away from cigarettes.
The regulatory green light comes at a time wheN the nicotine-pouch boom has already reshaped the conversation about alternatives to smoking. Nicotine pouches have become one of the fastest-growing nicotine categories globally, fueled by their discreet nature, lack of smoke or vapor, and growing perceptions that they represent a “cleaner” form of nicotine consumption.